Diagnostics
New blood test assists oncologists with tumour treatment optimization

New blood test assists oncologists with tumour treatment optimization

Washington: CellMax Life, a precision cancer blood-testing company, on Wednesday announced the availability of CellMax-LBx Liquid Biopsy in India. more

BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

New Delhi: BD (Becton, Dickinson and Company), a global medical technology company, on Wednesday announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of antimicrobial resistance (AMR). more

Respiratory diagnostics market expected to reach $7.45 billion by 2021

Respiratory diagnostics market expected to reach $7.45 billion by 2021

Pune: The global respiratory diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 7.3 percent and reach $7.45 billion by 2021 from $5.24 billion in 2016, according to a new market research report by MarketsandMarkets. more

Immunoassay market expected to reach $25.45 billion by 2021

Immunoassay market expected to reach $25.45 billion by 2021

Pune: The global immunoassay market is expected to grow at a CAGR of 8.2 per cent from $17.16 billion in 2016 to $25.45 billion by 2021, according to a new market research report by MarketsandMarkets. more

Point of care diagnostics market expected to reach $32.7 billion by 2022

Point of care diagnostics market expected to reach $32.7 billion by 2022

Pune: Global Point of Care Diagnostics Market is expected to grow at a CAGR (compound annual growth rate) of 9.7 percent to reach $32.7 billion by 2022, according to Wise Guy Reports. more

US FDA clears test to detect specific genetic markers for certain antibiotic-resistant bacteria

US FDA clears test to detect specific genetic markers for certain antibiotic-resistant bacteria

Washington: The US Food and Drug Administration on Wednesday cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to detect specific genetic markers associated with bacteria that are resistant to Carbapenem antibiotics. more

Medanta hospital partners with Australian university to improve epilepsy diagnosis in Indian villages

Medanta hospital partners with Australian university to improve epilepsy diagnosis in Indian villages

New Delhi: Swinburne University of Technology, Melbourne, Australia has signed an agreement with Medanta – The Medicity hospital, Gurgaon to improve the diagnosis of epilepsy in villages and remote communities across India. more

Positive Bioscience sets up its operations in Chennai, identifying medical institutions for partnerships

Positive Bioscience sets up its operations in Chennai, identifying medical institutions for partnerships

Mumbai: Positive Bioscience, a leading genomics testing company, is setting up its presence in Chennai to meet the emergent demand from the region. The company is identifying medical institutions for strategic partnerships. more

BD India to introduce new malaria detection platform that can provide diagnostic result in 4 minutes

BD India to introduce new malaria detection platform that can provide diagnostic result in 4 minutes

New Delhi: US-based medical technology company BD and Israel-based Sight Diagnostics (SightDX) have signed a deal under which BD will market SightDX Parasight Malaria Detection Platform in India. The collaboration will represent the first malaria diagnostics offering from BD. more

Four pathologists suspended for signing reports they didn’t test

Four pathologists suspended for signing reports they didn’t test

Mumbai: The Maharashtra Medical Council (MMC) has reportedly decided to remove the names of four pathologists, found to have signed pathology reports that they did not test or supervise, from the list of registered medical practitioners for six months. more